St. Jude Children’s Research Hospital is looking for participants in Memphis for a new clinical trial involving PrEP.
HPTN 083-01 is a clinical trial examining whether injectable cabotegravir (CAB) for PrEP (pre-exposure prophylaxis) is safe and acceptable for adolescent males (assigned male at birth –including transgender women (TGW), and gender-nonconforming people).
You may be eligible for this research study if:
- you are 17 years old and younger
- you are HIV uninfected
- you were assigned male at birth
- you have had or are interested in sexual experiences with male or transgender partners.
Get specific details about the study at inject2protect.org.
To learn more, please call or text the study staff at 901-216-1166 or email firstname.lastname@example.org.
To find out your eligibility please scan the QR code below and complete the pre-screening questionnaire.